Varex Imaging (VREX) Stock Price, News & Analysis

Company Overview

Varex Imaging Corporation (NASDAQ: VREX) develops and manufactures medical imaging components and X-ray products used by original equipment manufacturers, healthcare providers and other customers. Its portfolio includes X-ray tubes, digital detectors, image-processing software and other components that support diagnostic imaging, radiotherapy and industrial inspection systems.

The company’s products are used in a range of applications, including computed tomography, radiography, fluoroscopy, mammography, dental imaging, oncology and image-guided procedures. Varex also supplies imaging components for non-medical uses such as security screening, industrial inspection and scientific applications.

Varex serves customers worldwide through its international operations and distribution network. The company became an independent public company in 2017 following its separation from Varian Medical Systems, where its business had operated as the X-ray Products business.

Key Stats

• Today's Range: $18.48 to $18.50
• 50-Day Range: $10.95 to $18.58
• 52-Week Range: $9.09 to $18.63
• Volume: 31,351 shs
• Average Volume: 526,889 shs
• Market Capitalization: $778.22 million
• P/E Ratio: 35.55
• Dividend Yield: N/A
• Price Target: $16.88
• Consensus Rating: Hold

Varex Imaging Stock Analysis - MarketRank™

Varex Imaging scored higher than 43% of companies evaluated by MarketBeat, and ranked 586th out of 885 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Varex Imaging has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 7 hold ratings, and no sell ratings.

Downside Risk

Varex Imaging has a consensus price target of $16.88, representing about 8.5% downside from its current price of $18.45.

Amount of Analyst Coverage

Varex Imaging has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5.77%

Earnings Growth

Earnings for Varex Imaging are expected to grow by 5.77% in the coming year, from $1.04 to $1.10 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Varex Imaging is 35.48, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Varex Imaging is 35.48, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.34.

Price to Book Value per Share Ratio

Varex Imaging has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.50% of the float of Varex Imaging has been sold short.

Short Interest Ratio / Days to Cover

Varex Imaging has a short interest ratio ("days to cover") of 1.88, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Varex Imaging has recently increased by 12.09%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Varex Imaging does not currently pay a dividend.

Dividend Growth

Varex Imaging does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.58

News Sentiment

Varex Imaging has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Varex Imaging this week, compared to 2 articles on an average week.

Search Interest

Only 2 people have searched for VREX on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Varex Imaging insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,549,876.00 in company stock.

Percentage Held by Insiders

4.60% of the stock of Varex Imaging is held by insiders.

Percentage Held by Institutions

Varex Imaging has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/06/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:VREX
• CIK: 1681622
• Web: www.vareximaging.com
• Phone: (801) 972-5000
• Fax: N/A
• Employees: 2,400
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Varex Imaging: $16.88
• High Price Target: $19.00
• Low Price Target: $14.50
• Potential Upside/Downside: -8.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.52
• Trailing P/E Ratio: 35.55
• Forward P/E Ratio: 17.77
• P/E Growth: N/A
• Net Income: -$70.30 million
• Net Margins: 2.55%
• Pretax Margin: 3.20%
• Return on Equity: 9.19%
• Return on Assets: 4.13%

Debt

• Debt-to-Equity Ratio: 0.64
• Current Ratio: 3.38
• Quick Ratio: 1.53

Sales & Book Value

• Annual Sales: $865 million
• Price / Sales: 0.90
• Cash Flow: $3.88 per share
• Price / Cash Flow: 4.76
• Book Value: $11.73 per share
• Price / Book: 1.58

Miscellaneous

• Outstanding Shares: 42,100,000
• Free Float: 40,163,000
• Market Cap: $778.22 million
• Optionable: Optionable
• Beta: 0.97